• Product NameEnoxolone
• Brief DescriptionInhibitors
• Purification99.05%
• Biological ActivityEnoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.
• Target NameDehydrogenase inhibitor
• CAS No. 471-53-4
• Calculated MW 470.68
• Formulation C30H46O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)O
  Pathways:Metabolism
  Receptor:DHO
  Boling pt:588.3C?
  Melting pt:292-295C
  Solubility:DMSO: 94 mg/mL (199.71 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Boldt J, et al. Expert Opin PharmacOthers. 2007, 8(13):2135-47.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting